ENVESTNET ASSET MANAGEMENT INC

Position in ZYME — Zymeworks Inc.

CIK 1407543 Berwyn, PA

Position in ZYME

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$1,272,364

+$260,273 QoQ

Shares Held

48,675

+20.4% QoQ

Ownership

0.069%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#81

of 202 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ENVESTNET ASSET MANAGEMENT INC holds $901,256,539 across 108 Biotechnology names. ZYME ranks #57 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	487,627	$242,218,959
2	REGN	Regeneron Pharmaceuticals, Inc.	109,838	$68,488,386
3	EXEL	Exelixis, Inc.	949,669	$51,671,490
4	ARGX	Argenx SE	55,346	$51,348,358
5	ALNY	Alnylam Pharmaceuticals, Inc.	136,395	$41,058,986
6	INSM	INSMED Inc	336,997	$35,930,620
7	RPRX	Royalty Pharma plc	513,096	$28,769,292
8	ROIV	Roivant Sciences Ltd.	713,946	$25,266,548

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,272,364	48,675	+20.4%	Shares	Sole	2026-08-03
2026-03-31	$1,012,091	40,419	-1.0%	Shares	Sole	2026-05-04
2025-12-31	$1,074,579	40,812	+180.0%	Shares	Sole	2026-02-10
2025-09-30	$248,923	14,574	-0.2%	Shares	Sole	2025-11-05
2025-06-30	$183,305	14,606	-70.5%	Shares	Sole	2025-08-01
2025-03-31	$589,687	49,512	-8.5%	Shares	Sole	2025-04-29
2024-12-31	$791,877	54,090	-17.6%	Shares	Sole	2025-02-13
2024-09-30	$824,258	65,678	+4.8%	Shares	Sole	2024-11-07
2024-06-30	$533,440	62,684	-4.9%	Shares	Sole	2024-08-08
2024-03-31	$693,362	65,909	+32.5%	Shares	Sole	2024-05-13
2023-12-31	$517,006	49,760	+19.3%	Shares	Sole	2024-02-13
2023-09-30	$264,339	41,694	+43.7%	Shares	Sole	2023-11-13
2023-06-30	$250,603	29,005	+12.9%	Shares	Sole	2023-08-04
2023-03-31	$232,174	25,683	-54.3%	Shares	Sole	2023-05-11
2022-12-31	$441,456	56,165	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.